Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Stroke. 2020 Dec 22;52(1):213–222. doi: 10.1161/STROKEAHA.120.029685

Table 1.

Demographic and aneurysm characteristics

Parameter Total
(n=341)
Asymptomatic
aneurysms
(n=248)
Symptomatic
aneurysms
(n=93)
P Value
Age (years) 58.4±10.9 60.4±9.5 53.3±12.6 <0.001*
Female 202 (59.2) 141 (56.9) 61 (65.6) 0.14
Hypertension 222 (65.1) 174 (70.2) 48 (51.6) 0.001*
Dyslipidemia 166 (48.7) 121 (48.8) 45 (48.4) 0.95
Diabetes 55 (16.1) 40 (16.1) 15 (16.1) 1.00
Previous SAH 12 (3.5) 10 (4.0) 2 (2.2) 0.40
Current cigarette smoking 72 (21.1) 56 (22.6) 16 (17.2) 0.28
Alcohol consumption# 53 (15.5) 43 (17.3) 10 (10.8) 0.14
Aspirin intake 43 (12.6) 42 (16.9) 1 (1.1) 0.001*
Familial history of intracranial aneurysm 23 (6.7) 15 (6.0) 8 (8.6) 0.40
Posterior circulation 79 (23.2) 50 (20.2) 29 (31.2) 0.03*
Aneurysm size(mm) 5.4 (3.5, 8.4) 4.9 (3.3, 7) 7.1 (5, 12.3) <0.001*
Thrombus 34 (10.0) 14 (5.6) 20 (21.5) <0.001*
AWE pattern <0.001*
Pattern 0 188 (55.1) 171 (69) 17 (18.3)
Pattern 1 48 (14.1) 34 (13.7) 14 (15.1)
Pattern 2 105 (30.8) 43 (17.3) 62 (66.7)
MR imaging quantitative measures
WEI 0.5 (0.2, 1.3) 0.3 (0.1, 0.9) 1.3 (1, 1.9) <0.001*

The data of continuous variables are mean ± standard deviation or median (interquartile range) as appropriate. The data of categorical variables are expressed as n (%).

#

Alcohol consumption, current alcohol consumption > 15g/ day.

*

Statistically significant.

SAH, subarachnoid hemorrhage; AWE, aneurysms wall enhancement; WEI, wall enhancement index.